Annual ROE:
-54.00%-11.90%(-28.27%)Summary
- As of today, NTLA annual return on equity is -54.00%, with the most recent change of -11.90% (-28.27%) on December 31, 2024.
- During the last 3 years, NTLA annual ROE has fallen by -19.82% (-57.99%).
- NTLA annual ROE is now -136.63% below its all-time high of -22.82%, reached on December 31, 2016.
Performance
NTLA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-54.66%+1.17%(+2.10%)Summary
- As of today, NTLA quarterly return on equity is -54.66%, with the most recent change of +1.17% (+2.10%) on September 30, 2025.
- Over the past year, NTLA quarterly ROE has dropped by -3.02% (-5.85%).
- NTLA quarterly ROE is now -193.48% below its all-time high of 58.47%, reached on December 31, 2015.
Performance
NTLA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NTLA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -28.3% | -5.8% |
| 3Y3 Years | -58.0% | -18.9% |
| 5Y5 Years | -48.6% | -34.0% |
NTLA ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -58.0% | at low | -29.2% | +3.9% |
| 5Y | 5-Year | -60.3% | at low | -51.6% | +3.9% |
| All-Time | All-Time | -136.6% | +57.2% | -193.5% | +38.8% |
NTLA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -54.66%(+2.1%) |
| Jun 2025 | - | -55.83%(+1.9%) |
| Mar 2025 | - | -56.90%(-7.3%) |
| Dec 2024 | -54.00%(-28.3%) | -53.05%(-2.7%) |
| Sep 2024 | - | -51.64%(-5.5%) |
| Jun 2024 | - | -48.93%(-9.2%) |
| Mar 2024 | - | -44.79%(-4.6%) |
| Dec 2023 | -42.10%(-1.0%) | -42.82%(+0.1%) |
| Sep 2023 | - | -42.87%(+1.0%) |
| Jun 2023 | - | -43.29%(-2.3%) |
| Mar 2023 | - | -42.32%(+11.9%) |
| Dec 2022 | -41.67%(-21.9%) | -48.04%(-4.5%) |
| Sep 2022 | - | -45.98%(-2.8%) |
| Jun 2022 | - | -44.73%(-0.5%) |
| Mar 2022 | - | -44.49%(-23.4%) |
| Dec 2021 | -34.18%(-1.5%) | -36.05%(+5.3%) |
| Sep 2021 | - | -38.08%(+7.4%) |
| Jun 2021 | - | -41.14%(-10.8%) |
| Mar 2021 | - | -37.12%(+4.6%) |
| Dec 2020 | -33.69% | -38.89%(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -40.80%(+0.1%) |
| Jun 2020 | - | -40.83%(+0.4%) |
| Mar 2020 | - | -40.99%(-12.4%) |
| Dec 2019 | -36.34%(-23.2%) | -36.47%(-9.7%) |
| Sep 2019 | - | -33.25%(-1.3%) |
| Jun 2019 | - | -32.82%(-5.5%) |
| Mar 2019 | - | -31.12%(-3.3%) |
| Dec 2018 | -29.50%(-11.5%) | -30.12%(+12.2%) |
| Sep 2018 | - | -34.32%(-2.6%) |
| Jun 2018 | - | -33.46%(-1.7%) |
| Mar 2018 | - | -32.89%(-4.6%) |
| Dec 2017 | -26.46%(-16.0%) | -31.45%(-15.2%) |
| Sep 2017 | - | -27.31%(-22.6%) |
| Jun 2017 | - | -22.27%(-8.2%) |
| Mar 2017 | - | -20.58%(-15.9%) |
| Dec 2016 | -22.82%(+31.0%) | -17.75%(+33.7%) |
| Sep 2016 | - | -26.76%(+28.5%) |
| Jun 2016 | - | -37.41%(+58.1%) |
| Mar 2016 | - | -89.35%(-252.8%) |
| Dec 2015 | -33.09%(+73.8%) | 58.47% |
| Dec 2014 | -126.08% | - |
FAQ
- What is Intellia Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual ROE year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly ROE year-on-year change?
What is Intellia Therapeutics, Inc. annual return on equity?
The current annual ROE of NTLA is -54.00%
What is the all-time high annual ROE for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual return on equity is -22.82%
What is Intellia Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, NTLA annual return on equity has changed by -11.90% (-28.27%)
What is Intellia Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of NTLA is -54.66%
What is the all-time high quarterly ROE for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly return on equity is 58.47%
What is Intellia Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, NTLA quarterly return on equity has changed by -3.02% (-5.85%)